Adenosine Injection for SVT 3 mg/mL Antiarrhythmic Emergency Medication 2 mL Vial (EACH) (Rx)

Fast, Proven Solution for Supraventricular Tachycardia (SVT) and Acute Cardiac Arrhythmias.

Adenosine Injection 3 mg/mL, 2 mL Single Dose Vials by Sagent Pharmaceuticals is a leading emergency cardiac medication designed for rapid intravenous use. Trusted by hospitals and emergency medical teams, adenosine is clinically proven for the rapid conversion of paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm, including cases associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). This antiarrhythmic injection provides safe, effective support in critical arrhythmia management and acute cardiac care.

Key Benefits

• Immediate SVT Termination: Adenosine is the first-line medication for rapid control of paroxysmal supraventricular tachycardia (PSVT), restoring normal heart rhythm within seconds.
• Emergency Cardiac Care: Essential for Code Blue carts and advanced cardiac life support (ACLS) protocols.
• High Purity, Reliable Dosing: Each unit contains 6 mg (3 mg/mL in 2 mL vials) for predictable, standardized administration.
• User-Friendly Packaging: Single-use, ready-to-inject vials ensure sterility and speed when seconds count.
• Trusted Quality: Manufactured by Sagent Pharmaceuticals—FDA approved, adhering to highest safety and manufacturing standards.

Product Details

• Active Ingredient: Adenosine 3 mg per 1 mL (6 mg per 2 mL vial)
• Strength/Form: 3 mg/mL, 2 mL Single Dose Vial
• Route of Administration: Intravenous (IV) bolus injection
• NDC: [Enter appropriate NDC here]
• Latex-Free, Preservative-Free: Meets hospital safety standards

Clinical Indications

• Rapid Conversion of SVT/PSVT: Proven efficacy in terminating paroxysmal supraventricular tachycardia.
• Emergency Arrhythmia Management: Immediate effect in acute care, ER, and critical care environments.
• Pre-cardioversion Preparation: Used prior to or in conjunction with electrical cardioversion for arrhythmia patients.
• Wolff-Parkinson-White Syndrome: Useful for arrhythmias involving accessory conduits.

Adenosine is NOT effective for atrial fibrillation, atrial flutter, or ventricular tachycardia.

Administration

1. Rapid IV bolus via a large vein, followed immediately by saline flush.
2. Initial dose: 6 mg; if needed, may increase to 12 mg and repeat one time per medical protocol.
3. Monitor ECG and vital signs continuously during administration.
4. For hospital and emergency professional use only.

Always use as directed under physician supervision. For IV use only.

Why Choose Sagent Adenosine Injection?

• ACLS Recommended
• Critical in ER and ICU settings
• Packaged for rapid response
• Sterile, single dose for infection control
• Barcoded for patient safety

Top Health-Related Terms for Adenosine Injection:

• Adenosine injection for SVT
• Antiarrhythmic emergency medication
• Adenosine 3 mg/mL solution
• Paroxysmal supraventricular tachycardia treatment
• Adenosine for arrhythmia
• Emergency IV cardiac drug
• Rapid heart rhythm conversion
• ACLS preferred drugs
• SVT IV push
• Sagent Pharmaceuticals adenosine
• Acute coronary care medication

Safety & Precautions

• Side Effects: Common effects include transient flushing, chest discomfort, shortness of breath, lightheadedness, or brief asystole (expected and resolves rapidly). Rarely, severe allergic reactions or prolonged arrhythmias may occur.
• Contraindications: Do not use in patients with 2nd or 3rd degree AV block, sick sinus syndrome (unless patient has a functioning artificial pacemaker), or known hypersensitivity to adenosine.
• Special Populations: Use with caution in patients with asthma, as bronchospasm may occur.
• Drug Interactions: May interact with dipyridamole, carbamazepine, caffeine, theophylline. Inform your care team of all medications.

For hospital/clinical use only. Not intended for home use.

Buy Adenosine Injection 3 mg/mL, 2 mL Vial by Sagent Pharmaceuticals—The Gold Standard for Rapid Cardiac Arrhythmia Management